HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme.

Source:http://linkedlifedata.com/resource/pubmed/id/20071441

Download in:

View as

General Info

PMID
20071441